Direct answer (40-60 words)
Yes, in most cases. Brand-name GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda) are FSA and HSA eligible when prescribed by a licensed provider. Compounded semaglutide and tirzepatide are usually eligible with a Letter of Medical Necessity. Cosmetic-only weight loss without a documented medical condition can be denied.
Table of contents
- The 30-second answer
- The IRS rule that controls eligibility
- Brand-name GLP-1s: FSA and HSA status
- Compounded GLP-1s: the LMN question
- What a Letter of Medical Necessity actually is
- 2026 contribution limits and rollover rules
- How reimbursement actually works (3 paths)
- Real cost scenarios with FSA/HSA applied
- Common denial reasons and how to fix them
- FAQ
- Footer disclaimers
The IRS rule that controls eligibility
FSA and HSA eligibility is governed by IRS Publication 502 and Section 213(d) of the tax code. The short version: an expense is eligible when it is for the "diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of affecting any structure or function of the body."
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →That sentence is doing a lot of work. The IRS does not approve specific drugs. It approves categories of expense. A drug is eligible when:
- It is prescribed by a licensed provider, and
- It is treating a medical condition (not cosmetic preference), and
- It is not specifically excluded by your plan administrator.
Plan administrators (HSA Bank, HealthEquity, WageWorks, Optum Bank, etc.) have some latitude in how they apply the rule. Most follow IRS guidance closely. A few are stricter than the IRS. This is why the answer to "is X eligible" sometimes depends on which administrator runs your account.
Brand-name GLP-1s: FSA and HSA status
| Medication | FDA-approved indication | FSA eligible | HSA eligible | Documentation needed |
|---|---|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes | Yes | Yes | Prescription |
| Wegovy (semaglutide) | Chronic weight management at BMI 30+, or 27+ with comorbidity | Yes | Yes | Prescription |
| Mounjaro (tirzepatide) | Type 2 diabetes | Yes | Yes | Prescription |
| Zepbound (tirzepatide) | Chronic weight management at BMI 30+, or 27+ with comorbidity | Yes | Yes | Prescription |
| Saxenda (liraglutide) | Chronic weight management | Yes | Yes | Prescription |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Yes | Yes | Prescription |
The pattern: any GLP-1 with an active prescription written for an on-label or evidence-supported off-label use is eligible. The receipt from the pharmacy is usually all you need to submit. Most administrators accept the EOB or pharmacy receipt as documentation of medical necessity, because the prescription itself implies the diagnosis.
A common confusion: people assume that because Ozempic is FDA-approved only for diabetes (not weight loss), they cannot use FSA dollars when their doctor prescribes it off-label for weight management. The answer is more nuanced. If your provider documents a medical reason (often pre-diabetes, metabolic syndrome, or a related condition), the prescription qualifies. If the prescription is purely cosmetic, an administrator can deny.
In practice, most weight-management prescriptions document a medical condition, and most claims go through without trouble.
Compounded GLP-1s: the LMN question
Compounded semaglutide and tirzepatide are prepared by a state-licensed compounding pharmacy in response to an individual prescription. They are not FDA-approved and are not interchangeable with brand-name products.
Their FSA/HSA status is more nuanced than brand-name drugs.
The good news. Compounded medications are eligible expenses under IRS Section 213(d) when prescribed for a medical condition. The IRS does not require FDA approval, only a licensed provider's prescription and medical necessity.
The wrinkle. Many FSA and HSA administrators flag compounded GLP-1 claims for additional documentation. The flag does not mean denial. It means the administrator wants more than just a pharmacy receipt before reimbursing. They typically ask for one of:
- A Letter of Medical Necessity (LMN) signed by the prescribing provider, or
- A copy of the prescription with diagnosis code, or
- A patient statement of medical necessity countersigned by the provider
Once that documentation is on file, claims usually go through and stay through for the rest of the plan year.
The lesson is procedural: when you start a compounded GLP-1 program, ask the platform to send your provider's Letter of Medical Necessity directly. Saving it in a folder labeled "FSA documentation" prevents the back-and-forth later.
What a Letter of Medical Necessity actually is
An LMN is a one-page document signed by your treating clinician that states three things:
- Your name and the date of the assessment
- The diagnosis or medical condition being treated (BMI 30+, BMI 27+ with comorbidity, type 2 diabetes, prediabetes, metabolic syndrome, etc.)
- The specific medication being prescribed and the duration of treatment
Some administrators have a fillable form. Others accept any signed letter on the provider's letterhead with the elements above. The IRS does not require a specific format, only that the document supports medical necessity.
If you are a FormBlends patient, your assigned licensed provider can issue an LMN as part of your intake or on request. Ask once at the start of your program. You will not need to ask again until the next plan year.
2026 contribution limits and rollover rules
| Account | 2026 contribution limit | Rollover | Family limit |
|---|---|---|---|
| Healthcare FSA | $3,300 (individual) | Up to $660 carryover or 2.5-month grace period (employer choice) | n/a, individual account |
| Limited Purpose FSA | $3,300 | Same as healthcare FSA | n/a |
| HSA | $4,400 (individual) / $8,750 (family) | Full carryover, no limit | $8,750 |
| HSA catch-up (age 55+) | +$1,000 | Full carryover | Per spouse if both qualify |
| HRA | Set by employer | Set by employer | Set by employer |
A few practical points the IRS rule book does not spell out as clearly:
- HSA dollars never expire. You can build a multi-year balance and use it on GLP-1 therapy years later if you choose.
- FSA dollars are use-it-or-lose-it within the plan year, with employer-set carryover or grace period rules. Plan your contributions around expected GLP-1 spend.
- HSA-eligible plans require a high-deductible health plan (HDHP) for the year of contribution. You cannot contribute to an HSA if you are on a non-HDHP, even if you already have an HSA.
For 2026 GLP-1 spending, a common pattern is: $3,000 to $4,000 in annual GLP-1 cost, fully covered by an HSA balance, indexed to your highest-protection-deductible year.
How reimbursement actually works (3 paths)
Path 1: Use the FSA/HSA debit card directly at the pharmacy. The simplest. You swipe the card, the prescription is recognized as a medical expense, the transaction goes through. Works for nearly all brand-name GLP-1 fills at retail pharmacies. Sometimes does not work for compounded medications dispensed by mail-order compounding pharmacies, because the merchant code is not always classified as "pharmacy." If the card is declined, move to Path 2 or 3.
Path 2: Pay out of pocket, submit a claim for reimbursement. Pay with a regular card or bank account. Save the pharmacy receipt and (for compounded medications) the Letter of Medical Necessity. Log into your plan administrator's portal and upload the documentation. Reimbursement usually arrives within 5 to 10 business days.
Path 3: Pay out of pocket, save documentation, and reimburse yourself later (HSA only). This is HSA-specific. Because HSA dollars never expire and you can reimburse yourself for any qualifying expense from any past year (as long as the HSA was open when the expense occurred), some patients pay cash now and reimburse themselves five years later. The documentation requirement is the same: receipt plus LMN if compounded.
Most patients use Path 1 for brand-name and Path 2 for compounded. Both are clean.
Real cost scenarios with FSA/HSA applied
Scenario 1: Wegovy via insurance, FSA copay
- Monthly copay: $250
- Annual cost: $3,000
- Paid from FSA: $3,000
- Effective tax savings (24% bracket): $720
- Real out-of-pocket after tax savings: $2,280
Scenario 2: Compounded tirzepatide cash pay, HSA
- Monthly cost: $329 through a telehealth platform
- Annual cost: $3,948
- Paid from HSA: $3,948 with LMN on file
- Effective tax savings (32% combined federal/state): $1,263
- Real out-of-pocket after tax savings: $2,685
Scenario 3: Mounjaro savings card stacked with HSA
- With savings card: $25 per month for eligible patients
- Annual cost: $300
- Paid from HSA: $300
- Effective tax savings (24% bracket): $72
- Real out-of-pocket after tax savings: $228
Scenario 4: Zepbound cash pay, no FSA/HSA
- Monthly cash price: $1,059
- Annual cost: $12,708
- Paid from FSA/HSA: $0 (account not enrolled)
- This is the scenario most patients want to avoid by enrolling in an FSA or HSA before starting therapy
The takeaway from the math: stacking FSA/HSA dollars on top of either insurance copay or compounded cash pricing is the meaningful lever. It cuts effective cost by 20 to 35% depending on tax bracket.
For more on the cost side of brand-name access, see related guide. For the difference between brand-name and compounded products, see related guide.
Common denial reasons and how to fix them
"Documentation insufficient." The administrator wants more than a pharmacy receipt. Submit the prescription with diagnosis code or a Letter of Medical Necessity.
"Not an eligible expense." Usually means the merchant code at the compounding pharmacy was unclear. Resubmit through the manual claim path with the LMN.
"Out of plan year." The expense was incurred outside the plan year window. FSAs are year-bound. HSAs are not. If it is an FSA issue and you have unused dollars, plan ahead next year.
"Cosmetic procedure." Rare with GLP-1 prescriptions. If it happens, the fix is providing the LMN that documents BMI, comorbidity, or metabolic condition.
"Compounded medication not covered." Some plan administrators have stricter rules than the IRS. Read the plan summary. If there is a blanket exclusion, you cannot fix that one. You can switch to Path 3 (HSA only, reimburse later) or use the dollars on other eligible expenses.
If you hit a denial, do not give up after the first try. The appeal rate of overturned GLP-1 claims with proper documentation is high. An LMN turns most denials into approvals.
A note on insurance vs FSA/HSA
These are different systems. Insurance pays a portion of your prescription according to your plan's formulary. FSA/HSA pays the remaining out-of-pocket portion using pre-tax dollars. They stack.
The order at the pharmacy:
- Insurance processes the claim and applies its portion.
- The remaining patient responsibility (copay, coinsurance, or full cash price) is what you owe.
- You pay that remaining portion using your FSA or HSA card, or you pay out of pocket and reimburse yourself.
This is why people on commercial insurance with a $250 Wegovy copay can still use $250 of FSA dollars to pay it. The pre-tax savings on that copay over a year is real money.
FAQ
1. Is tirzepatide FSA eligible?
Yes, when prescribed by a licensed provider. This applies to brand-name Mounjaro and Zepbound and to compounded tirzepatide with a Letter of Medical Necessity.
2. Is compounded semaglutide HSA eligible?
Yes, with documentation. Most administrators ask for a Letter of Medical Necessity for compounded products. Once that is on file, claims process normally.
3. Do I need a prescription to use FSA/HSA dollars on GLP-1s?
Yes. The IRS rule requires a prescription for medications. Over-the-counter is now FSA/HSA eligible without a prescription, but no GLP-1 is over-the-counter.
4. Can I use FSA dollars for Wegovy if my BMI is below 30?
If your provider documents another medical condition (BMI 27+ with comorbidity such as hypertension, sleep apnea, or dyslipidemia), yes. The prescription needs a medical reason behind it.
5. What is the FSA contribution limit for 2026?
$3,300 for healthcare FSA. The IRS adjusts annually. Family carryover is up to $660 if your employer offers it.
6. What is the HSA contribution limit for 2026?
$4,400 individual, $8,750 family. Plus $1,000 catch-up if you are 55 or older.
7. Do FSA dollars roll over to the next year?
Most FSAs allow up to $660 carryover, or a 2.5-month grace period to spend them. Employer chooses one or the other. Anything beyond that is forfeited.
8. Does an HSA require a high-deductible health plan?
Yes, to make new contributions. You can keep an existing HSA balance even if you switch to a non-HDHP, but you cannot add new dollars while non-HDHP-enrolled.
9. Will my FSA card work at a compounding pharmacy?
Sometimes. If the merchant code is recognized as pharmacy, yes. If not, the card may decline. The fix is paying out of pocket and submitting the claim manually with documentation.
10. Can I use FSA dollars at FormBlends or a similar telehealth platform?
Yes for the medication portion when documentation is provided. Some platform service fees may not be eligible (administrative or membership fees usually are not). Ask the platform to itemize the receipt so the medication line is clearly separated.
11. What documentation should I save?
Pharmacy receipt, prescription with diagnosis code (or LMN), and any platform invoice that shows what was billed. Save these for at least three years in case of audit.
12. What if my plan administrator says compounded GLP-1s are not eligible?
Read the plan documents. If there is a blanket exclusion, you cannot override it through your employer's FSA. You can still use HSA dollars (HSA rules follow the IRS, not the employer). For FSA, check whether the exclusion is "compounded medications" or only "non-FDA-approved drugs" and ask for clarification before submitting the claim.
Author / review note
Reviewed by the FormBlends Medical Team. References include IRS Publication 502 (2025), IRS Section 213(d) of the tax code, Revenue Procedure 2024-25 (2026 HSA limits), and IRS guidance on Letters of Medical Necessity.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, and Rybelsus are registered trademarks of their respective owners (Novo Nordisk and Eli Lilly). FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →